Discovery of a Pentapeptide Antagonist to Human Neuromedin U Receptor 1

Kentaro Takayama, Kenji Mori,Yu Sasaki, Akihiro Taguchi,Atsuhiko Taniguchi, Mikiya Miyazato,Yoshio Hayashi

ACS MEDICINAL CHEMISTRY LETTERS(2024)

引用 0|浏览2
暂无评分
摘要
Neuromedin U (NMU) activates two types of receptors (NMUR1 and NMUR2), and the former is mainly expressed in the peripheral tissues, including the intestinal tract and lung tissues. Since NMUR1 contributes to the promotion of type 2 inflammation in these tissues, it is a potential target to suppress inflammatory responses. However, promising antagonist candidates for human NMUR1 have not yet been developed. Here we successfully identified pentapeptide antagonist 9a through a structure-activity relationship study based on hexapeptide lead 1. Its antagonistic activity against human NMUR1 was 10 times greater than that against NMUR2. This is a breakthrough in the development of NMUR1-selective antagonists. Although 9a was relatively stable in the plasma, the C-terminal amide was rapidly degraded to the carboxylic acid by the serum endopeptidase thrombin, which acted as an amidase. This basic information would aid in sample handling in future biological evaluations.
更多
查看译文
关键词
Amidase,Antagonist,Human neuromedinU receptor1,Peptide,Thrombin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要